Mead Johnson Nutrition

What Mead Johnson Nutrition does

Mead Johnson Nutrition is a global infant and pediatric nutrition company founded in 1905 and headquartered in Evansville, Indiana, operating as a wholly-owned subsidiary of Reckitt Benckiser Group plc since its June 2017 acquisition. The company manufactures and sells infant formula and children's nutritional products under the Enfamil brand, which is the #1 pediatrician-recommended infant formula in the United States. Its product portfolio spans standard infant formulas, specialized preterm and medical nutrition products (including Enfamil Premature 24 and acidified liquid human milk fortifier for NICU use), and premium MFGM-enriched formulas backed by a five-year clinical study in Mainland China demonstrating cognitive, language, motor, and attention benefits.

Mead Johnson's core technology centers on proprietary nutritional formulations, including being the first in the U.S. to introduce DHA into infant formula (2002) and developing the world's first MFGM-enriched infant formula (2016). The company is one of only two manufacturers of preterm infant formula in the U.S. (alongside Abbott Laboratories), and together the two companies produce approximately half of all baby formula sold in the country. It operates 5,001-10,000 employees across the U.S., eight Latin American countries (Argentina, Brazil, Colombia, Dominican Republic, Ecuador, Mexico, Peru, Venezuela), and Asia-Pacific markets including the Philippines and Hong Kong.

The company's revenue model is based on one-time product sales through two primary channels: enterprise field sales to hospitals and NICUs for specialized preterm formulas, and retail/pharmacy plus direct e-commerce (enfamil.com) distribution for consumer products. Mead Johnson generates revenue from both B2B institutional procurement and consumer purchases, supported by clinical research-driven marketing to healthcare professionals and pediatrician endorsement. The company is currently facing material NEC-related litigation, with over 775 lawsuits consolidated in the Northern District of Illinois and potential liability estimated between £400 million and £8 billion; Reckitt Benckiser is reportedly exploring a sale of the Mead Johnson division.

Name

Mead Johnson Nutrition

Legal name

Mead Johnson & Company, LLC

Website

https://meadjohnson.com

Company type

Private

Founded year

1905

Operating status

Operating

Headcount range

11–50 employees

Short description

Mead Johnson Nutrition manufactures and sells infant formula and pediatric nutrition products under the Enfamil brand, serving parents, caregivers, and NICU hospitals globally as a wholly-owned subsidiary of Reckitt Benckiser Group plc.

Ownership category

akta.pro rank

Product category

Infant and Pediatric Nutrition

SIC

Dairy Products (2020)

akta.pro primary industry

Infant Formula & Specialized Dairy Nutrition Manufacturing (AFAKAKAJ)

akta.pro secondary industries

Specialty & Medical Infant Formula (Hypoallergenic, Lactose-Free, Metabolic) (CRADAEAB), Baby Nutrition for Premature/Low Birth Weight Infants (CRADAEAN), Functional Baby & Kids Foods Manufacturing (Fortified Infant/Toddler Foods, Kids Nutrition) (AFAKAJAJ)

Keywords

• Infant formula
• Pediatric nutrition
• Neonatal nutrition
• Preterm infant formula
• Human milk fortifier

Headquarters

HQ city

Glenview

HQ country

United States

HQ region

North America

Offices10 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Technology or R&D, Personnel

Revenue model

1. Infant Formula Sales: Sale of infant and pediatric nutrition products including Enfamil branded formulas, specialized preterm formulas, and fortifiers through hospital and retail channels.
2. Specialized Medical Nutrition: Sale of specialized formulas for premature infants and infants with specific nutritional needs, sold through healthcare institutions and retail.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Mead Johnson Nutrition manufactures and sells the Enfamil family of infant and pediatric nutritional products. Its portfolio spans standard infant formulas, MFGM- and DHA-enriched formulas, specialized premature infant formulas such as Enfamil Premature 24, and an acidified liquid human milk fortifier used in hospital NICU settings, alongside consumer retail and e-commerce offerings distributed globally.

Product overview

Mead Johnson Nutrition is a global infant and child nutrition company (subsidiary of Reckitt Benckiser Group plc since June 2017) offering a portfolio centered on its flagship Enfamil brand of infant formulas. The company provides standard infant formulas, specialized formulas for premature infants (Enfamil Premature 24), and premium MFGM-enriched formulas developed through extensive clinical research. With a 120-year heritage in pediatric nutrition innovation—including pioneering DHA introduction in 2002 and MFGM enrichment in 2016—Mead Johnson serves the NICU market with specialized medical nutrition products alongside its mass-market consumer offerings.

Differentiator

Problem solved

Functional benefit

Brands

• Enfamil: Leading infant formula brand, including Enfamil Premature 24 for premature infants. Enfamil is the top infant formula recommended by pediatricians in the U.S.
• Enfamil Premature 24

Products and services

• Enfamil Infant Formula Family Flagship line of Mead Johnson infant formulas sold to parents and caregivers through retail, pharmacy, and e-commerce channels, and used by healthcare professionals for routine infant feeding.
• MFGM- and DHA-Enriched Infant Formula Infant formula enriched with milk fat globule membrane (MFGM) and DHA, positioned with brain and developmental nutrition claims and supported by published clinical research.
• Enfamil Premature 24 Specialized premature infant formula formulated for preterm and low-birth-weight infants in hospital and NICU settings.
• Acidified Liquid Human Milk Fortifier Acidified liquid fortifier used in hospital NICUs to enhance the nutritional content of human milk for preterm and medically fragile infants.

Quantifiable outcome

• 40% faster speed to market during 2022 infant formula crisis
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered minor and core.

• Medical ConspiracyminorStrategic or Co-development Partner · 15 September 2025Mead Johnson Nutrition Hong Kong collaborated with Medical Conspiracy to host a Paediatric Nutrition Symposium on September 15, 2025, in Hong Kong. Over 100 healthcare professionals attended to discuss research on Milk Fat Globule Membrane (MFGM) and infant brain development. The symposium featured a five-year clinical study conducted by Mead Johnson in Mainland China demonstrating cognitive benefits of MFGM-containing formula.
• Mainland China Research InstitutionsminorStrategic or Co-development Partner · 15 September 2025Mead Johnson conducted a five-year clinical study in Mainland China on Milk Fat Globule Membrane (MFGM) and infant brain development, demonstrating that infants consuming MFGM-containing formula during their first year achieved superior cognitive, language, motor, and sustained attention outcomes compared to a control group.
• IBMcoreStrategic or Co-development Partner · 1 January 2009IBM provides strategic and tactical procurement services for Mead Johnson, including strategic purchasing (supplier selection and negotiation), tactical purchasing (quote and bid administration), purchase order processing, catalog implementation and administration, and supplier database management for certain service and indirect product categories. IBM also handles invoice processing for accounts payable for direct and indirect products and services. This partnership was part of Mead Johnson's 2009 transformation initiative to implement industry best practices and SAP technology globally.

Scale indicators8 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Abbott Laboratories: Abbott's Nutrition division produces Similac, the direct head-to-head competitor to Enfamil in U.S. infant formula, including the preterm/preemie segment (Similac Neosure). Together they manufacture roughly half of all U.S. baby formula, creating a clear two-player duopoly Mead Johnson competes in.
• Hero Group (Beech-Nut / Organix): Hero owns Beech-Nut Nutrition, a direct specialty infant formula peer in the U.S. market, and Organix in Europe. Its positioning around clean-label and organic baby food closely mirrors key elements of Mead Johnson's Enfamil positioning.
• Perrigo Company: Perrigo is the largest U.S. store-brand infant formula manufacturer, supplying retailers' private-label formulas including those sold alongside Enfamil. It competes with Mead Johnson across the value tier and benefits from the same regulatory framework.

Broad incumbents

• Nestlé Nutrition: Nestlé is one of the four global infant nutrition players (with Reckitt/Mead Johnson, Danone, and Abbott) and competes via the NAN and Gerber Good Start brands. While not a direct U.S. duopoly competitor, it is a comparable global infant nutrition incumbent with similar regulatory and supply chain exposure.
• Danone Nutricia: Danone's Nutricia division produces Aptamil and Karicare, the dominant European infant formula brands, and is a top-5 global infant nutrition player. It is comparable to Mead Johnson across specialty medical nutrition (Nutricia specialized formulas) and global retail.

Emerging players

• Bobbie Baby: Bobbie is an emerging organic infant formula brand in the U.S. that competes for premium, parent-driven share against Enfamil. It focuses on a subset of the market (organic, direct-to-consumer) and represents the new wave of branded infant nutrition entrants.
• ByHeart: ByHeart is a venture-backed U.S. infant formula startup emphasizing whole-milk and clinically differentiated nutrition, directly challenging Enfamil's premium positioning. It targets the same pediatrician-influenced parent buyer.

Regional players

• Yili Group: Yili is China's largest dairy producer and operates a major infant formula business (including the Satine and Pro-Kido brands). It is a regional peer to Mead Johnson in Asia-Pacific where Mead Johnson is investing via Hong Kong and the Mainland China MFGM clinical trial.
• Beingmate: Beingmate is a leading Chinese infant formula brand competing with Mead Johnson's Enfamil product line in the Mainland China market, particularly relevant given Mead Johnson's recent 5-year MFGM clinical study conducted in China.
• Synutra International / Mengniu: Chinese infant formula manufacturers including Mengniu and Synutra are key regional competitors in the Asia-Pacific infant nutrition market where Mead Johnson is expanding its MFGM and DHA-positioned products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/meadjohnson

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mead Johnson Nutrition